Our Services
Others
- DFPP
- Shockwave
- IV Drip
Chronic knee pain and degenerative joint conditions affect millions of individuals worldwide, limiting mobility and diminishing quality of life. These problems can arise from natural aging, sports injuries, repetitive strain, obesity, or long-standing conditions such as osteoarthritis. For many patients, conventional treatments provide only temporary relief, often leading to a gradual progression toward invasive surgical options such as knee replacement.
Traditional knee care typically includes pain-relieving medications, physical therapy, corticosteroid injections, or viscosupplementation. While these methods may help manage symptoms, they do little to restore damaged cartilage or reverse joint degeneration. As a result, patients often experience recurring pain and declining joint function. In recent years, regenerative medicine has emerged as an innovative alternative, focusing on repairing injured tissues rather than masking discomfort. Among these advancements, umbilical cord–derived mesenchymal stem cell (UC-MSC) therapy has gained global recognition for its regenerative capacity and safety profile.
What Are Umbilical Cord–Derived Mesenchymal Stem Cells?
Umbilical cord–derived mesenchymal stem cells are harvested from Wharton’s jelly, a soft, protective tissue surrounding the blood vessels of the umbilical cord. These cells are collected after healthy, full-term births through voluntary donation, making the process ethical, non-invasive, and risk-free for both mother and newborn. Once collected, the cells are carefully processed and preserved under strict laboratory standards.
UC-MSCs are biologically young, meaning they possess a higher capacity for replication, adaptability, and regenerative signaling compared with adult stem cells obtained from bone marrow or adipose tissue. Their youthful nature allows them to function more efficiently in damaged or inflamed environments. Additionally, these cells have low immunogenicity, which means they are unlikely to trigger immune rejection. This characteristic allows them to be used safely across a wide range of patients without the need for extensive donor matching.
When introduced into the knee joint, UC-MSCs interact with surrounding tissues by releasing growth factors, cytokines, and extracellular vesicles. These biological signals activate repair pathways, regulate inflammation, and create a joint environment conducive to healing and regeneration.
How Stem Cells Support Knee Joint Regeneration
Stem Cell Treatment Methods Used in Thailand
Benefits of Stem Cell Therapy for Knee Conditions
Why Thailand Is a Leader in Regenerative Knee Care
Thailand has become a global destination for regenerative medicine due to its advanced medical infrastructure, experienced specialists, and commitment to international safety standards. Stem cells are processed in certified laboratories that follow strict quality control protocols. Many clinics also integrate regenerative treatment with customized rehabilitation and physiotherapy programs, maximizing functional recovery and long-term outcomes.
Conclusion
Umbilical cord–derived mesenchymal stem cell therapy represents a significant advancement in the treatment of knee degeneration and chronic joint pain. By activating the body’s natural healing mechanisms, this approach goes beyond symptom management to restore damaged cartilage, strengthen bone, and reduce inflammation at its source. For individuals seeking a non-surgical, long-term solution to knee problems, stem cell therapy offers renewed hope for improved mobility, comfort, and quality of life. With its expertise in regenerative medicine, Thailand continues to stand at the forefront of innovative and high-quality knee care.